118 related articles for article (PubMed ID: 1921449)
1. Morphologic and flow cytometric analysis of circulating megakaryoblasts in chronic myeloid leukaemia.
Matolcsy A; Kálmán E; Pajor L; Kónya T; Weber E
Leuk Res; 1991; 15(10):887-97. PubMed ID: 1921449
[TBL] [Abstract][Full Text] [Related]
2. Circulating megakaryoblasts in chronic myeloproliferative diseases. An immunoelectron-microscopic study.
Matolcsy A; Majdic O
Acta Haematol; 1990; 84(2):57-63. PubMed ID: 2120886
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocyte markers in myeloproliferative disorders.
Iványi JL; Kiss A; Telek B; Tornai I
Acta Histochem; 1993 Sep; 95(1):79-88. PubMed ID: 7506475
[TBL] [Abstract][Full Text] [Related]
5. Human megakaryocyte polyploidization is associated with a decrease in GPIIIA expression.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1999; 19(6B):5187-9. PubMed ID: 10697532
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor 4 mRNA expression in cells from a patient with megakaryoblastic crisis of chronic myelogenous leukemia.
Ryo R; Adachi M; Sugano W; Yasunaga M; Yoshida A; Jikai J; Saigo K; Yamaguchi N; Akita H; Yokoyama M
Cancer; 1991 Feb; 67(4):960-4. PubMed ID: 1991266
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
López-Karpovitch X; Cárdenas R; Piedras J
Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
[TBL] [Abstract][Full Text] [Related]
8. Dual-color flow cytometric analysis of megakaryocytic DNA ploidy in the investigation of blastic phase chronic myelogenous leukemia with rearrangement of 3q26.
Kwong YL; Robertson EP; Lee CP; Chan LC
Cancer; 1993 Jun; 71(12):3882-7. PubMed ID: 8508354
[TBL] [Abstract][Full Text] [Related]
9. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia.
Nair C; Chopra H; Shinde S; Barbhaya S; Kumar A; Dhond S; Yejamanam B; Sapre R; Chougule A; Advani S
Leuk Lymphoma; 1995 Oct; 19(3-4):309-13. PubMed ID: 8535224
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic changes in the megakaryocyte-platelet lineage.
Stenberg PE
Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
16. [Megakaryoblastic crisis of chronic myelogenous leukemia cytological and clinical studies in three cases].
Ikegami T; Hasegawa Y; Hanada T; Nakazawa M; Abe T
Rinsho Ketsueki; 1989 Jun; 30(6):898-903. PubMed ID: 2795902
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural analysis of megakaryoblasts by simultaneous detection of platelet peroxidase and platelet glycoproteins.
Kishimoto Y; Nagano T; Kimura T; Adachi M; Tatsumi E; Ryo R; Yamaguchi N; Yasunaga K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):102-12. PubMed ID: 2741643
[TBL] [Abstract][Full Text] [Related]
18. JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis.
Di Noto R; Luciano L; Lo Pardo C; Ferrara F; Frigeri F; Mercuro O; Lombardi ML; Pane F; Vacca C; Manzo C; Salvatore F; Rotoli B; Del Vecchio L
Leukemia; 1997 Sep; 11(9):1554-64. PubMed ID: 9305612
[TBL] [Abstract][Full Text] [Related]
19. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
[TBL] [Abstract][Full Text] [Related]
20. Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes.
Tomer A
Blood; 2004 Nov; 104(9):2722-7. PubMed ID: 15198950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
